Načítá se...
Conversion surgery in patients with pancreatic cancer and peritoneal metastasis
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal malignancies globally. We have previously explored the clinical efficacy of intraperitoneal (IP) paclitaxel therapy for patients with PDAC and peritoneal metastasis, which demonstrated favourable response and disease contro...
Uloženo v:
| Vydáno v: | J Gastrointest Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8100706/ https://ncbi.nlm.nih.gov/pubmed/33968431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-243 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|